6 Results for "

mouse model of NASH

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "mouse model of NASH" in MCE Product Catalog:

Cat. No.: HY-P99697
CAS No.: 674782-26-4
Synonyms: PRO 140

Target:  

CCR HIV

Research Areas:  

Infection Cancer

Leronlimab (PRO 140) is a humanized IgG4 anti-CCR5 monoclonal antibody. Leronlimab inhibits CCR5-mediated HIV-1 viral and lung metastasis in mouse tumor models. Leronlimab can be used for the research of HIV nonalcoholic steatohepatitis (NASH) and cancer .
loading...
    loading...
Cat. No.: HY-164799
CAS No.: 1831862-88-4
Target:  

FXR

Research Areas:  

Inflammation/Immunology

FXR agonist 12 (Compound C7) is the orally active agonist for FXR. FXR agonist 12 down-regulates bile acid synthesis-related genes, and up-regulates bile acid transport-related genes in HepG2 cells. FXR agonist 12 improves ANIT-induced cholestasis, ameliorates the liver damage and fibrosis in mouse NASH models .
loading...
    loading...
Cat. No.: HY-172105
CAS No.: 3028778-28-8
Target:  

PPAR

Anti-NASH agent 2 (compound 21) is an inhibitor of de novo adipogenesis activity and α-SMA gene expression. Anti-NASH agent 2 improves hepatic steatosis, edema, inflammatory infiltrates, and liver fibrosis in NASH mouse models .
loading...
    loading...
Cat. No.: HY-168327
Target:  

FXR

Research Areas:  

Inflammation/Immunology

LH10 is a fexaramine-based agonist for FXR with an EC50 of 0.14 μM. LH10 exhibits liver protection efficacy, ameliorates the alpha naphthylisothiocyanate (ANIT)-induced cholestasis, APAP (HY-66005)-induced acute liver injury and non-alcoholic steatohepatitis (NASH) in mouse models .
loading...
    loading...
Cat. No.: HY-181792
Target:  

STAT

Research Areas:  

Inflammation/Immunology

ZDZ-553 is an orally active STAT1 inhibitor with an IC50 value of 0.87 μM. ZDZ-553 modulates STAT1 signaling to affect downstream lipid metabolism and inflammatory pathways. ZDZ-553 attenuates hepatic steatosis in NASH mouse models. ZDZ-553 reduces inflammatory responses in NASH mouse models. ZDZ-553 can be used for the research of nonalcoholic steatohepatitis .
loading...
    loading...
Cat. No.: HY-181896S
PPARγ agonist-23 (Compound 9) is an orally active PPARγ agonist with an EC50 of 0.32 μM. PPARγ agonist-23 improves hepatic triglyceride levels, reduces scores of steatosis and hepatocellular ballooning, and decreases the total activity score of non-alcoholic steatohepatitis (NASH). PPARγ agonist-23 can be used for the research of non-alcoholic steatohepatitis .
loading...
    loading...